Extrait

The purpose of the protocol is to assess the efficacy and safety of BIM 23A760 on patient's overall satisfaction in terms of symptom relief (diarrhoea and/or flushes) in patients with carcinoid syndrome after 24 weeks of treatment.

Critère d'inclusion

• Carcinoid Syndrome

Pays

• Austria
• Belgium
• Czech Republic
• Finland
• France
• Germany
• Ireland
• Israel
• Italy
• Latvia
• Netherlands
• Poland
• Russian Federation
• Slovakia
• Spain
• Sweden
• Ukraine
• United Kingdom

Liens

• nct